0 XP   0   0   0

Carasent ASA
Buy, Hold or Sell?

Should you buy, hold or sell Carasent?

I guess you are interested in Carasent ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Carasent

Let's start. I'm going to help you getting a better view of Carasent ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Carasent ASA even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Carasent ASA is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Carasent ASA. The closing price on 2023-03-21 was kr14.48 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Carasent ASA Daily Candlestick Chart
Carasent ASA Daily Candlestick Chart
Summary









1. Valuation of Carasent




Current price per share

kr14.48

2. Growth of Carasent




Is Carasent growing?

Current yearPrevious yearGrowGrow %
How rich?$117.4m$64.7m$50.1m43.7%

How much money is Carasent making?

Current yearPrevious yearGrowGrow %
Making money$1.1m-$771k$1.8m168.9%
Net Profit Margin26.6%-34.6%--

How much money comes from the company's main activities?

3. Financial Health of Carasent




Comparing to competitors in the Health Information Services industry




  Industry Rankings (Health Information Services)  


Richest
#60 / 167

Most Revenue
#110 / 167

Most Profit
#36 / 167


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Carasent ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Carasent earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Net Profit Margin of 22.0% means that kr0.22 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Carasent ASA:

  • The MRQ is 22.0%. The company is making a huge profit. +2
  • The TTM is 26.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.0%TTM26.6%-4.6%
TTM26.6%YOY-34.6%+61.1%
TTM26.6%5Y-7.2%+33.8%
5Y-7.2%10Y3.7%-10.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ22.0%-29.1%+51.1%
TTM26.6%-37.9%+64.5%
YOY-34.6%-27.2%-7.4%
5Y-7.2%-38.2%+31.0%
10Y3.7%-52.8%+56.5%
1.1.2. Return on Assets

Shows how efficient Carasent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • 0.8% Return on Assets means that Carasent generated kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Carasent ASA:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.9%-0.1%
TTM0.9%YOY-1.4%+2.3%
TTM0.9%5Y0.8%+0.1%
5Y0.8%10Y5.3%-4.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-5.5%+6.3%
TTM0.9%-7.5%+8.4%
YOY-1.4%-3.8%+2.4%
5Y0.8%-8.5%+9.3%
10Y5.3%-8.5%+13.8%
1.1.3. Return on Equity

Shows how efficient Carasent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • 0.8% Return on Equity means Carasent generated kr0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Carasent ASA:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.0%-0.1%
TTM1.0%YOY-1.8%+2.7%
TTM1.0%5Y0.6%+0.4%
5Y0.6%10Y4.5%-3.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-7.0%+7.8%
TTM1.0%-9.6%+10.6%
YOY-1.8%-4.5%+2.7%
5Y0.6%-11.1%+11.7%
10Y4.5%-12.2%+16.7%

1.2. Operating Efficiency of Carasent ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Carasent is operating .

  • Measures how much profit Carasent makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • An Operating Margin of 0.1% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Carasent ASA:

  • The MRQ is 0.1%. The company is operating inefficient. -1
  • The TTM is 23.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM23.6%-23.5%
TTM23.6%YOY-30.9%+54.5%
TTM23.6%5Y-5.9%+29.6%
5Y-5.9%10Y4.9%-10.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-28.3%+28.4%
TTM23.6%-33.5%+57.1%
YOY-30.9%-21.0%-9.9%
5Y-5.9%-33.1%+27.2%
10Y4.9%-43.2%+48.1%
1.2.2. Operating Ratio

Measures how efficient Carasent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are kr1.18 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Carasent ASA:

  • The MRQ is 1.180. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.072. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.180TTM1.072+0.108
TTM1.072YOY0.943+0.129
TTM1.0725Y0.891+0.181
5Y0.89110Y0.892-0.001
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1801.545-0.365
TTM1.0721.543-0.471
YOY0.9431.361-0.418
5Y0.8911.350-0.459
10Y0.8921.406-0.514

1.3. Liquidity of Carasent ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Carasent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 9.06 means the company has kr9.06 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Carasent ASA:

  • The MRQ is 9.063. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.589. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.063TTM8.589+0.475
TTM8.589YOY8.872-0.284
TTM8.5895Y11.574-2.986
5Y11.57410Y7.137+4.437
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0632.053+7.010
TTM8.5892.055+6.534
YOY8.8722.319+6.553
5Y11.5742.300+9.274
10Y7.1372.262+4.875
1.3.2. Quick Ratio

Measures if Carasent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Quick Ratio of 0.32 means the company can pay off kr0.32 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Carasent ASA:

  • The MRQ is 0.322. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 4.345. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM4.345-4.024
TTM4.345YOY8.820-4.475
TTM4.3455Y10.661-6.315
5Y10.66110Y6.535+4.126
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3221.514-1.192
TTM4.3451.524+2.821
YOY8.8201.684+7.136
5Y10.6611.608+9.053
10Y6.5351.693+4.842

1.4. Solvency of Carasent ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Carasent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Carasent to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.09 means that Carasent assets are financed with 8.7% credit (debt) and the remaining percentage (100% - 8.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Carasent ASA:

  • The MRQ is 0.087. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.093. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.093-0.006
TTM0.093YOY0.169-0.076
TTM0.0935Y0.184-0.090
5Y0.18410Y0.302-0.118
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0870.415-0.328
TTM0.0930.394-0.301
YOY0.1690.373-0.204
5Y0.1840.419-0.235
10Y0.3020.442-0.140
1.4.2. Debt to Equity Ratio

Measures if Carasent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Debt to Equity ratio of 9.6% means that company has kr0.10 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Carasent ASA:

  • The MRQ is 0.096. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.103. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.096TTM0.103-0.007
TTM0.103YOY0.208-0.105
TTM0.1035Y0.244-0.141
5Y0.24410Y0.588-0.344
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0960.588-0.492
TTM0.1030.601-0.498
YOY0.2080.552-0.344
5Y0.2440.657-0.413
10Y0.5880.652-0.064

2. Market Valuation of Carasent ASA

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Carasent generates.

  • Above 15 is considered overpriced but always compare Carasent to the Health Information Services industry mean.
  • A PE ratio of 137.65 means the investor is paying kr137.65 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Carasent ASA:

  • The EOD is 110.728. Seems overpriced? -1
  • The MRQ is 137.646. Seems overpriced? -1
  • The TTM is 323.729. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD110.728MRQ137.646-26.917
MRQ137.646TTM323.729-186.084
TTM323.729YOY-149.606+473.336
TTM323.7295Y515.615-191.886
5Y515.61510Y346.822+168.793
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD110.728-2.353+113.081
MRQ137.646-4.910+142.556
TTM323.729-7.286+331.015
YOY-149.606-17.965-131.641
5Y515.615-10.319+525.934
10Y346.822-10.319+357.141
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Carasent.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Carasent ASA:

  • The MRQ is 31.781. Seems overpriced? -1
  • The TTM is 1,954.145. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ31.781TTM1,954.145-1,922.364
TTM1,954.145YOY33.745+1,920.400
TTM1,954.1455Y1,291.817+662.328
5Y1,291.81710Y1,115.744+176.073
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ31.781-0.755+32.536
TTM1,954.145-1.323+1,955.468
YOY33.7450.077+33.668
5Y1,291.817-2.244+1,294.061
10Y1,115.7441.267+1,114.477

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Carasent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 1.16 means the investor is paying kr1.16 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Carasent ASA:

  • The EOD is 0.931. Very good. +2
  • The MRQ is 1.157. Good. +1
  • The TTM is 1.715. Good. +1
Trends
Current periodCompared to+/- 
EOD0.931MRQ1.157-0.226
MRQ1.157TTM1.715-0.559
TTM1.715YOY5.651-3.936
TTM1.7155Y4.259-2.544
5Y4.25910Y2.974+1.286
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD0.9311.755-0.824
MRQ1.1572.450-1.293
TTM1.7152.903-1.188
YOY5.6515.203+0.448
5Y4.2593.997+0.262
10Y2.9744.263-1.289
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Carasent ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1750.216-19%2.542-93%0.738-76%0.353-50%
Book Value Growth--1.0111.0140%1.399-28%1.247-19%1.126-10%
Book Value Per Share--15.55815.075+3%8.576+81%5.544+181%3.380+360%
Book Value Per Share Growth--1.0111.0150%1.399-28%1.247-19%1.126-10%
Current Ratio--9.0638.589+6%8.872+2%11.574-22%7.137+27%
Debt To Asset Ratio--0.0870.093-6%0.169-48%0.184-52%0.302-71%
Debt To Equity Ratio--0.0960.103-7%0.208-54%0.244-61%0.588-84%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps--0.1310.146-10%-0.102+178%0.009+1420%0.035+270%
Eps Growth--4.3312.405+80%1.153+276%-3.879+190%-2.091+148%
Free Cash Flow Per Share---0.231-0.124-46%-0.002-99%-0.038-84%-0.019-92%
Free Cash Flow Per Share Growth--0.746-16.507+2311%1.735-57%-2.269+404%-0.209+128%
Free Cash Flow To Equity Per Share---0.255-0.138-46%3.236-108%0.588-143%0.173-248%
Free Cash Flow To Equity Per Share Growth--0.792-0.489+162%54.872-99%13.330-94%3.131-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--45.418--------
Intrinsic Value_10Y_min---93.505--------
Intrinsic Value_1Y_max--0.596--------
Intrinsic Value_1Y_min---2.017--------
Intrinsic Value_3Y_max--4.806--------
Intrinsic Value_3Y_min---12.465--------
Intrinsic Value_5Y_max--12.649--------
Intrinsic Value_5Y_min---29.852--------
Net Profit Margin--0.2200.266-17%-0.346+257%-0.072+133%0.037+487%
Operating Margin--0.0010.236-99%-0.309+21944%-0.059+4305%0.049-97%
Operating Ratio--1.1801.072+10%0.943+25%0.891+32%0.892+32%
Pb Ratio0.931-24%1.1571.715-33%5.651-80%4.259-73%2.974-61%
Pe Ratio110.728-24%137.646323.729-57%-149.606+209%515.615-73%346.822-60%
Peg Ratio--31.7811954.145-98%33.745-6%1291.817-98%1115.744-97%
Price Per Share14.480-24%18.00025.663-30%39.163-54%17.142+5%9.592+88%
Price To Total Gains Ratio82.871-24%103.017-5.255+105%-31.679+131%918.219-89%444.757-77%
Profit Growth--4.3312.417+79%1.153+276%-3.876+189%-2.015+147%
Quick Ratio--0.3224.345-93%8.820-96%10.661-97%6.535-95%
Return On Assets--0.0080.009-13%-0.014+282%0.008-1%0.053-85%
Return On Equity--0.0080.010-14%-0.018+311%0.006+45%0.045-81%
Revenue Growth--1.0181.065-4%1.206-16%1.130-10%1.028-1%
Total Gains Per Share--0.1750.216-19%2.542-93%0.739-76%0.353-50%
Total Gains Per Share Growth--0.3051.565-80%6.914-96%18.569-98%10.425-97%
Usd Book Value--117430750.800114891224.700+2%64729297.800+81%42066998.628+179%25619734.013+358%
Usd Book Value Change Per Share--0.0170.020-19%0.241-93%0.070-76%0.033-50%
Usd Book Value Per Share--1.4751.429+3%0.813+81%0.526+181%0.320+360%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps--0.0120.014-10%-0.010+178%0.001+1420%0.003+270%
Usd Free Cash Flow---1746121.200-940297.500-46%-17182.500-99%-284464.651-84%-139889.629-92%
Usd Free Cash Flow Per Share---0.022-0.012-46%0.000-99%-0.004-84%-0.002-92%
Usd Free Cash Flow To Equity Per Share---0.024-0.013-46%0.307-108%0.056-143%0.016-248%
Usd Price Per Share1.373-24%1.7062.433-30%3.713-54%1.625+5%0.909+88%
Usd Profit--987057.6001118687.400-12%-771008.400+178%68751.877+1336%268463.478+268%
Usd Revenue--4492666.8004235308.500+6%2782403.700+61%1982822.580+127%3560113.470+26%
Usd Total Gains Per Share--0.0170.020-19%0.241-93%0.070-76%0.033-50%
 EOD+3 -2MRQTTM+16 -23YOY+20 -195Y+19 -2210Y+18 -23

3.2. Fundamental Score

Let's check the fundamental score of Carasent ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15110.728
Price to Book Ratio (EOD)Between0-10.931
Net Profit Margin (MRQ)Greater than00.220
Operating Margin (MRQ)Greater than00.001
Quick Ratio (MRQ)Greater than10.322
Current Ratio (MRQ)Greater than19.063
Debt to Asset Ratio (MRQ)Less than10.087
Debt to Equity Ratio (MRQ)Less than10.096
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.008
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Carasent ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.372
Ma 20Greater thanMa 5015.540
Ma 50Greater thanMa 10016.082
Ma 100Greater thanMa 20016.717
OpenGreater thanClose14.700
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-09-302021-12-312022-03-312022-06-302022-09-30
Retained Earnings  -45,4409,000-36,44025,389-11,0512,404-8,64710,4121,765



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in NOK. All numbers in thousands.

Summary
Total Assets1,357,197
Total Liabilities118,476
Total Stockholder Equity1,238,721
 As reported
Total Liabilities 118,476
Total Stockholder Equity+ 1,238,721
Total Assets = 1,357,197

Assets

Total Assets1,357,197
Total Current Assets782,874
Long-term Assets782,874
Total Current Assets
Cash And Cash Equivalents 750,789
Net Receivables 27,802
Other Current Assets 1
Total Current Assets  (as reported)782,874
Total Current Assets  (calculated)778,592
+/- 4,282
Long-term Assets
Property Plant Equipment 20,462
Goodwill 374,504
Intangible Assets 179,357
Long-term Assets  (as reported)574,323
Long-term Assets  (calculated)574,323
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities86,378
Long-term Liabilities32,098
Total Stockholder Equity1,238,721
Total Current Liabilities
Accounts payable 10,569
Other Current Liabilities 34,518
Total Current Liabilities  (as reported)86,378
Total Current Liabilities  (calculated)45,087
+/- 41,291
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt20,099
Other Liabilities 19,937
Long-term Liabilities  (as reported)32,098
Long-term Liabilities  (calculated)40,036
+/- 7,938
Total Stockholder Equity
Common Stock105,892
Retained Earnings 1,765
Total Stockholder Equity (as reported)1,238,721
Total Stockholder Equity (calculated)107,657
+/- 1,131,064
Other
Capital Stock105,892
Common Stock Shares Outstanding 79,498
Net Invested Capital 1,238,721
Net Tangible Assets 684,860
Net Working Capital 696,496



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
194,235
219,320
231,433
204,624
196,308
184,448
176,941
194,771
200,164
188,314
204,715
193,828
212,590
224,037
230,117
222,378
224,321
219,675
239,649
239,945
228,205
237,336
235,879
327,559
217,572
179,971
170,312
161,208
50,268
49,902
43,853
66,378
61,775
60,949
108,482
107,921
119,243
116,935
114,583
112,434
136,660
151,054
155,881
444,097
504,950
495,930
899,255
1,315,023
1,300,818
1,335,795
1,352,452
1,357,197
1,357,1971,352,4521,335,7951,300,8181,315,023899,255495,930504,950444,097155,881151,054136,660112,434114,583116,935119,243107,921108,48260,94961,77566,37843,85349,90250,268161,208170,312179,971217,572327,559235,879237,336228,205239,945239,649219,675224,321222,378230,117224,037212,590193,828204,715188,314200,164194,771176,941184,448196,308204,624231,433219,320194,235000
   > Total Current Assets 
0
0
0
33,629
34,138
34,638
29,628
24,345
21,711
21,989
22,880
22,986
23,583
28,849
28,026
28,787
35,403
37,463
34,014
37,128
39,391
37,411
33,267
38,304
38,774
41,937
204,958
93,029
64,469
56,477
54,407
11,394
9,328
7,425
28,070
61,775
60,949
15,328
15,363
18,815
15,998
16,180
16,405
19,620
20,329
23,754
311,209
237,939
237,091
513,283
923,614
909,465
814,642
800,811
782,874
782,874800,811814,642909,465923,614513,283237,091237,939311,20923,75420,32919,62016,40516,18015,99818,81515,36315,32860,94961,77528,0707,4259,32811,39454,40756,47764,46993,029204,95841,93738,77438,30433,26737,41139,39137,12834,01437,46335,40328,78728,02628,84923,58322,98622,88021,98921,71124,34529,62834,63834,13833,629000
       Cash And Cash Equivalents 
0
0
0
11,805
11,198
7,733
6,852
5,679
5,182
5,170
4,620
4,584
4,624
7,951
9,860
13,165
15,118
15,608
13,108
18,999
15,513
13,325
14,851
19,390
12,997
12,256
181,458
68,565
43,043
28,138
32,652
11,307
9,182
7,165
27,887
61,570
60,793
8,061
7,905
8,773
7,175
7,241
8,259
10,928
9,386
9,854
12,313
220,254
217,666
486,770
894,635
882,772
787,946
771,186
750,789
750,789771,186787,946882,772894,635486,770217,666220,25412,3139,8549,38610,9288,2597,2417,1758,7737,9058,06160,79361,57027,8877,1659,18211,30732,65228,13843,04368,565181,45812,25612,99719,39014,85113,32515,51318,99913,10815,60815,11813,1659,8607,9514,6244,5844,6205,1705,1825,6796,8527,73311,19811,805000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,321
6,582
9,278
7,638
7,829
6,813
8,131
9,063
11,992
297,124
14,588
17,759
23,816
26,019
23,548
23,295
26,055
27,802
27,80226,05523,29523,54826,01923,81617,75914,588297,12411,9929,0638,1316,8137,8297,6389,2786,5826,3210000000000000000000000000000000000000
       Other Current Assets 
0
0
0
21,824
22,940
26,905
22,776
18,666
16,529
16,820
18,260
18,402
18,959
20,898
18,166
15,622
20,286
21,854
20,906
18,129
23,878
24,086
18,416
18,914
25,777
29,681
23,500
24,464
21,426
28,339
21,755
86
146
260
183
205
156
7,267
7,458
10,042
8,823
8,939
8,146
8,692
10,943
13,900
298,896
17,685
19,425
26,513
28,979
26,693
26,696
1
1
1126,69626,69328,97926,51319,42517,685298,89613,90010,9438,6928,1468,9398,82310,0427,4587,2671562051832601468621,75528,33921,42624,46423,50029,68125,77718,91418,41624,08623,87818,12920,90621,85420,28615,62218,16620,89818,95918,40218,26016,82016,52918,66622,77626,90522,94021,824000
   > Long-term Assets 
0
0
0
160,606
185,182
196,795
174,996
171,964
162,737
154,952
171,890
177,178
164,730
175,866
165,803
183,803
188,634
192,654
188,364
187,192
180,284
202,238
206,678
189,900
198,562
193,943
122,602
124,543
115,502
113,835
106,801
38,874
40,575
36,428
38,308
0
0
93,154
92,558
100,428
100,937
98,403
96,029
117,040
130,725
132,127
132,888
267,011
258,839
385,972
391,409
391,354
521,153
551,641
574,323
574,323551,641521,153391,354391,409385,972258,839267,011132,888132,127130,725117,04096,02998,403100,937100,42892,55893,1540038,30836,42840,57538,874106,801113,835115,502124,543122,602193,943198,562189,900206,678202,238180,284187,192188,364192,654188,634183,803165,803175,866164,730177,178171,890154,952162,737171,964174,996196,795185,182160,606000
       Property Plant Equipment 
0
0
0
26,542
44,904
45,504
39,316
36,496
32,969
30,464
38,273
40,307
34,820
39,822
35,345
57,568
57,047
56,067
53,478
51,901
46,718
66,415
64,445
69,345
69,154
66,024
36,297
35,496
31,761
29,488
25,887
0
0
0
0
0
0
0
0
678
4,054
1,123
937
17,652
18,679
17,649
16,763
17,115
15,010
19,355
17,754
16,118
16,875
22,629
20,462
20,46222,62916,87516,11817,75419,35515,01017,11516,76317,64918,67917,6529371,1234,0546780000000025,88729,48831,76135,49636,29766,02469,15469,34564,44566,41546,71851,90153,47856,06757,04757,56835,34539,82234,82040,30738,27330,46432,96936,49639,31645,50444,90426,542000
       Goodwill 
0
0
0
125,815
0
0
0
127,266
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,520
56,550
61,535
16,103
57,117
57,601
58,813
64,851
64,842
65,404
170,339
165,909
275,878
275,675
271,990
366,036
372,646
374,504
374,504372,646366,036271,990275,675275,878165,909170,33965,40464,84264,85158,81357,60157,11716,10361,53556,55056,52000000000000000000000000000000127,266000125,815000
       Intangible Assets 
0
0
0
8,249
140,278
151,291
135,680
8,201
129,769
124,488
133,618
0
129,911
136,043
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,907
35,320
38,216
80,779
40,162
37,491
40,576
47,195
49,636
50,721
78,440
76,803
89,622
96,864
102,919
137,915
156,367
179,357
179,357156,367137,915102,91996,86489,62276,80378,44050,72149,63647,19540,57637,49140,16280,77938,21635,32035,90700000000000000000000000136,043129,9110133,618124,488129,7698,201135,680151,291140,2788,249000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
727
688
-1
1
2
-1
0
-1
2
0
1,116
1,118
1,118
1,116
51,060
327
-1
0
0-132751,0601,1161,1181,1181,11602-10-121-16887270000000000000000000000000000000000000
> Total Liabilities 
0
0
0
72,804
98,668
105,768
95,936
89,718
82,896
78,037
85,896
86,130
78,615
87,900
78,565
97,744
101,200
101,245
93,704
93,529
90,037
106,948
99,246
146,303
147,063
144,603
172,500
146,106
111,245
99,233
89,581
1,219
608
863
3,058
509
2,635
24,573
23,877
27,811
27,020
25,035
21,897
46,083
50,182
60,723
83,700
103,973
110,618
124,245
145,128
129,543
122,869
127,643
118,476
118,476127,643122,869129,543145,128124,245110,618103,97383,70060,72350,18246,08321,89725,03527,02027,81123,87724,5732,6355093,0588636081,21989,58199,233111,245146,106172,500144,603147,063146,30399,246106,94890,03793,52993,704101,245101,20097,74478,56587,90078,61586,13085,89678,03782,89689,71895,936105,76898,66872,804000
   > Total Current Liabilities 
0
0
0
44,378
75,559
84,235
79,451
51,928
49,793
48,111
50,757
51,523
75,466
81,433
72,542
48,596
53,248
54,274
47,897
47,418
74,884
78,097
75,848
123,463
89,599
91,756
117,390
94,664
72,750
64,009
57,847
1,219
608
863
3,058
509
2,635
14,021
13,269
17,331
15,591
16,730
16,872
21,010
22,949
26,222
38,200
41,158
39,168
64,860
58,673
109,047
95,735
94,867
86,378
86,37894,86795,735109,04758,67364,86039,16841,15838,20026,22222,94921,01016,87216,73015,59117,33113,26914,0212,6355093,0588636081,21957,84764,00972,75094,664117,39091,75689,599123,46375,84878,09774,88447,41847,89754,27453,24848,59672,54281,43375,46651,52350,75748,11149,79351,92879,45184,23575,55944,378000
       Short-term Debt 
0
0
0
14,454
38,038
40,940
44,540
18,983
17,780
16,385
19,624
20,873
44,598
46,468
41,138
18,497
18,419
18,914
17,097
16,664
43,901
49,123
53,461
64,460
30,235
29,382
29,415
28,543
34,488
27,014
21,908
0
0
0
0
0
0
0
0
0
1,444
966
409
3,458
3,918
4,214
4,560
5,746
5,061
6,167
5,817
5,703
6,428
0
0
006,4285,7035,8176,1675,0615,7464,5604,2143,9183,4584099661,44400000000021,90827,01434,48828,54329,41529,38230,23564,46053,46149,12343,90116,66417,09718,91418,41918,49741,13846,46844,59820,87319,62416,38517,78018,98344,54040,94038,03814,454000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
930
643
278
851
742
730
736
943
586
302
0
0
0
0
0
000003025869437367307428512786439300000000000000000000000000000000000000000
       Accounts payable 
0
0
0
12,377
15,042
22,377
15,411
13,333
11,397
10,893
9,333
8,506
7,461
8,655
6,482
7,292
10,839
10,438
7,563
6,963
11,801
8,781
9,630
11,346
11,393
14,097
9,746
16,816
9,445
10,492
11,542
510
34
8
1,978
8
407
3,043
4,853
3,343
2,234
2,396
2,056
1,917
2,254
2,084
14,927
4,883
3,503
15,230
6,735
8,942
10,119
10,734
10,569
10,56910,73410,1198,9426,73515,2303,5034,88314,9272,0842,2541,9172,0562,3962,2343,3434,8533,04340781,97883451011,54210,4929,44516,8169,74614,09711,39311,3469,6308,78111,8016,9637,56310,43810,8397,2926,4828,6557,4618,5069,33310,89311,39713,33315,41122,37715,04212,377000
       Other Current Liabilities 
0
0
0
17,547
22,479
20,918
19,500
19,612
20,616
20,834
21,800
22,144
23,407
26,310
24,923
22,807
23,990
24,923
23,237
23,791
19,182
20,193
12,756
47,657
47,971
48,277
78,229
49,306
28,817
26,503
24,397
709
574
855
1,080
501
2,228
10,978
8,416
13,988
11,913
13,368
14,407
15,635
16,777
19,924
18,713
30,529
30,604
43,463
46,121
94,402
79,188
27,887
34,518
34,51827,88779,18894,40246,12143,46330,60430,52918,71319,92416,77715,63514,40713,36811,91313,9888,41610,9782,2285011,08085557470924,39726,50328,81749,30678,22948,27747,97147,65712,75620,19319,18223,79123,23724,92323,99022,80724,92326,31023,40722,14421,80020,83420,61619,61219,50020,91822,47917,547000
   > Long-term Liabilities 
0
0
0
28,426
23,109
21,533
16,485
37,790
33,103
29,926
35,138
34,607
3,149
6,467
6,023
49,149
47,952
46,971
45,807
46,111
15,152
28,851
23,398
22,840
57,464
52,848
55,110
51,442
38,495
35,225
31,734
0
0
0
0
0
0
10,552
10,608
10,480
11,429
8,305
5,025
25,073
27,233
34,501
45,500
62,815
71,450
59,385
86,455
20,496
27,134
32,776
32,098
32,09832,77627,13420,49686,45559,38571,45062,81545,50034,50127,23325,0735,0258,30511,42910,48010,60810,55200000031,73435,22538,49551,44255,11052,84857,46422,84023,39828,85115,15246,11145,80746,97147,95249,1496,0236,4673,14934,60735,13829,92633,10337,79016,48521,53323,10928,426000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,553
7,566
7,254
6,660
6,378
7,696
9,787
11,326
19,738
31,780
50,053
60,455
45,668
74,159
9,863
16,716
18,616
19,937
19,93718,61616,7169,86374,15945,66860,45550,05331,78019,73811,3269,7877,6966,3786,6607,2547,5667,5530000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,735
0
0
0
00050,735000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
121,431
120,652
125,665
108,688
106,590
101,552
98,904
108,875
114,034
109,699
116,815
115,263
114,846
122,838
128,872
128,674
130,791
129,638
132,702
140,699
81,902
90,273
91,276
155,059
71,466
68,726
71,079
71,628
49,049
49,294
42,990
63,320
61,266
58,314
83,909
84,044
91,432
89,915
89,548
90,537
90,577
100,872
95,158
360,397
400,976
385,313
775,010
1,169,895
1,171,275
1,212,926
1,224,809
1,238,721
1,238,7211,224,8091,212,9261,171,2751,169,895775,010385,313400,976360,39795,158100,87290,57790,53789,54889,91591,43284,04483,90958,31461,26663,32042,99049,29449,04971,62871,07968,72671,466155,05991,27690,27381,902140,699132,702129,638130,791128,674128,872122,838114,846115,263116,815109,699114,034108,87598,904101,552106,590108,688125,665120,652121,431000
   Common Stock
0
0
0
27,116
27,116
27,116
27,116
27,431
26,055
25,074
27,082
27,850
26,573
27,812
26,764
26,051
27,309
28,349
28,031
28,377
28,022
28,612
30,076
34,691
37,411
36,705
39,542
41,016
38,794
39,133
37,582
40,335
39,966
39,102
37,061
38,315
27,116
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
73,307
73,307
88,752
104,719
104,719
105,892
105,892
105,892
105,892105,892105,892104,719104,71988,75273,30773,30754,12454,12454,12454,12454,12454,12454,12454,12454,12454,12427,11638,31537,06139,10239,96640,33537,58239,13338,79441,01639,54236,70537,41134,69130,07628,61228,02228,37728,03128,34927,30926,05126,76427,81226,57327,85027,08225,07426,05527,43127,11627,11627,11627,116000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000-8710000000-14400000000000-182,955000-140,444000-108,739000-81,079000-79,642000-65,1440000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
432,488
456,916
458,509
458,999
552,170
441,066
424,886
459,249
575,727
451,393
472,784
455,260
546,390
465,007
482,970
477,718
616,378
477,822
488,012
513,085
761,542
638,372
626,376
674,831
828,561
578,009
583,072
559,965
508,757
463,015
452,996
429,357
443,882
34,149
35,819
35,918
35,963
35,818
35,819
35,819
35,819
35,819
35,819
309,473
364,830
355,970
710,289
1,110,616
1,102,996
1,118,085
-5,788
-2,288
-2,288-5,7881,118,0851,102,9961,110,616710,289355,970364,830309,47335,81935,81935,81935,81935,81935,81835,96335,91835,81934,149443,882429,357452,996463,015508,757559,965583,072578,009828,561674,831626,376638,372761,542513,085488,012477,822616,378477,718482,970465,007546,390455,260472,784451,393575,727459,249424,886441,066552,170458,999458,509456,916432,488000



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.